Skip to content

Research at St Andrews

Influence of zinc on glycosaminoglycan neutralisation during coagulation

Research output: Contribution to journalReview articlepeer-review

DOI

Open Access permissions

Open

Standard

Influence of zinc on glycosaminoglycan neutralisation during coagulation. / Sobczak, Amélie I. S.; Pitt, Samantha J.; Stewart, Alan J.

In: Metallomics, Vol. 10, No. 9, 09.2018, p. 1180-1190.

Research output: Contribution to journalReview articlepeer-review

Harvard

Sobczak, AIS, Pitt, SJ & Stewart, AJ 2018, 'Influence of zinc on glycosaminoglycan neutralisation during coagulation', Metallomics, vol. 10, no. 9, pp. 1180-1190. https://doi.org/10.1039/C8MT00159F

APA

Sobczak, A. I. S., Pitt, S. J., & Stewart, A. J. (2018). Influence of zinc on glycosaminoglycan neutralisation during coagulation. Metallomics, 10(9), 1180-1190. https://doi.org/10.1039/C8MT00159F

Vancouver

Sobczak AIS, Pitt SJ, Stewart AJ. Influence of zinc on glycosaminoglycan neutralisation during coagulation. Metallomics. 2018 Sep;10(9):1180-1190. https://doi.org/10.1039/C8MT00159F

Author

Sobczak, Amélie I. S. ; Pitt, Samantha J. ; Stewart, Alan J. / Influence of zinc on glycosaminoglycan neutralisation during coagulation. In: Metallomics. 2018 ; Vol. 10, No. 9. pp. 1180-1190.

Bibtex - Download

@article{8b319b1752a54b8b982bc435c2c99d43,
title = "Influence of zinc on glycosaminoglycan neutralisation during coagulation",
abstract = "Heparan sulfate (HS), dermatan sulfate (DS) and heparin are glycosaminoglycans (GAGs) that serve as key natural and pharmacological anticoagulants. During normal clotting such agents require to be inactivated or neutralised. Several proteins have been reported to facilitate their neutralisation, which reside in platelet α-granules and are released following platelet activation. These include histidine-rich-glycoprotein (HRG), fibrinogen and high-molecular-weight kininogen (HMWK). Zinc ions (Zn2+) are also present in α-granules at a high concentration and participate in the propagation of coagulation by influencing the binding of neutralising proteins to GAGs. Zn2+ in many cases increases the affinity of these proteins to GAGs, and is thus an important regulator of GAG neutralisation and haemostasis. Binding of Zn2+ to HRG, HMWK and fibrinogen is mediated predominantly through coordination to histidine residues but the mechanisms by which Zn2+ increases the affinity of the proteins for GAGs are not yet completely clear. Here we will review current knowledge of how Zn2+ binds to and influences the neutralisation of GAGs and describe the importance of this process in both normal and pathogenic clotting.",
keywords = "Anticoagulants, Blood clotting, Heparin, Platelets, Zinc",
author = "Sobczak, {Am{\'e}lie I. S.} and Pitt, {Samantha J.} and Stewart, {Alan J.}",
note = "This work was supported by the British Heart Foundation (grant codes: PG/15/9/31270 and FS/15/42/31556). SJP is supported by a Royal Society of Edinburgh Biomedical Fellowship.",
year = "2018",
month = sep,
doi = "10.1039/C8MT00159F",
language = "English",
volume = "10",
pages = "1180--1190",
journal = "Metallomics",
issn = "1756-5901",
publisher = "Royal Society of Chemistry",
number = "9",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Influence of zinc on glycosaminoglycan neutralisation during coagulation

AU - Sobczak, Amélie I. S.

AU - Pitt, Samantha J.

AU - Stewart, Alan J.

N1 - This work was supported by the British Heart Foundation (grant codes: PG/15/9/31270 and FS/15/42/31556). SJP is supported by a Royal Society of Edinburgh Biomedical Fellowship.

PY - 2018/9

Y1 - 2018/9

N2 - Heparan sulfate (HS), dermatan sulfate (DS) and heparin are glycosaminoglycans (GAGs) that serve as key natural and pharmacological anticoagulants. During normal clotting such agents require to be inactivated or neutralised. Several proteins have been reported to facilitate their neutralisation, which reside in platelet α-granules and are released following platelet activation. These include histidine-rich-glycoprotein (HRG), fibrinogen and high-molecular-weight kininogen (HMWK). Zinc ions (Zn2+) are also present in α-granules at a high concentration and participate in the propagation of coagulation by influencing the binding of neutralising proteins to GAGs. Zn2+ in many cases increases the affinity of these proteins to GAGs, and is thus an important regulator of GAG neutralisation and haemostasis. Binding of Zn2+ to HRG, HMWK and fibrinogen is mediated predominantly through coordination to histidine residues but the mechanisms by which Zn2+ increases the affinity of the proteins for GAGs are not yet completely clear. Here we will review current knowledge of how Zn2+ binds to and influences the neutralisation of GAGs and describe the importance of this process in both normal and pathogenic clotting.

AB - Heparan sulfate (HS), dermatan sulfate (DS) and heparin are glycosaminoglycans (GAGs) that serve as key natural and pharmacological anticoagulants. During normal clotting such agents require to be inactivated or neutralised. Several proteins have been reported to facilitate their neutralisation, which reside in platelet α-granules and are released following platelet activation. These include histidine-rich-glycoprotein (HRG), fibrinogen and high-molecular-weight kininogen (HMWK). Zinc ions (Zn2+) are also present in α-granules at a high concentration and participate in the propagation of coagulation by influencing the binding of neutralising proteins to GAGs. Zn2+ in many cases increases the affinity of these proteins to GAGs, and is thus an important regulator of GAG neutralisation and haemostasis. Binding of Zn2+ to HRG, HMWK and fibrinogen is mediated predominantly through coordination to histidine residues but the mechanisms by which Zn2+ increases the affinity of the proteins for GAGs are not yet completely clear. Here we will review current knowledge of how Zn2+ binds to and influences the neutralisation of GAGs and describe the importance of this process in both normal and pathogenic clotting.

KW - Anticoagulants

KW - Blood clotting

KW - Heparin

KW - Platelets

KW - Zinc

UR - https://europepmc.org/articles/PMC6148461

U2 - 10.1039/C8MT00159F

DO - 10.1039/C8MT00159F

M3 - Review article

VL - 10

SP - 1180

EP - 1190

JO - Metallomics

JF - Metallomics

SN - 1756-5901

IS - 9

ER -

Related by author

  1. Albumin-mediated alteration of plasma zinc speciation by fatty acids modulates blood clotting in type-2 diabetes

    Sobczak, A. I. S., Katundu, K. G. H., Phoenix, F. A., Khazaipoul, S., Yu, R., Lampiao, F., Stefanowicz, F., Blindauer, C. A., Pitt, S. J., Smith, T. K., Ajjan, R. A. & Stewart, A. J., 1 Feb 2021, In: Chemical Science. Advance Article, 15 p.

    Research output: Contribution to journalArticlepeer-review

  2. Reduced plasma magnesium levels in type-1 diabetes associate with prothrombotic changes in fibrin clotting and fibrinolysis

    Sobczak, A. I. S., Phoenix, F. A., Pitt, S. J., Ajjan, R. A. & Stewart, A. J., Feb 2020, In: Thrombosis and Haemostasis. 120, 2, p. 243-252 10 p.

    Research output: Contribution to journalArticlepeer-review

  3. Plasma non-esterified fatty acids contribute to increased coagulability in type-2 diabetes through altered plasma zinc speciation

    Sobczak, A. I. S., Katundu, K. G. H., Phoenix, F. A., Khazaipoul, S., Yu, R., Lampiao, F., Stefanowicz, F., Blindauer, C. A., Pitt, S. J., Smith, T. K., Ajjan, R. A. & Stewart, A. J., 28 Aug 2019, In: biorxiv. 2019, 38 p.

    Research output: Contribution to journalArticle

  4. Total plasma magnesium, zinc, copper and selenium concentrations in type-I and type-II diabetes

    Sobczak, A. I. S., Stefanowicz, F., Pitt, S. J., Ajjan, R. A. & Stewart, A. J., Feb 2019, In: BioMetals. 32, 1, p. 123-138 16 p.

    Research output: Contribution to journalArticlepeer-review

Related by journal

  1. A metalloproteomic analysis of interactions between plasma proteins and zinc: elevated fatty acid levels affect zinc distribution

    Coverdale, J. P. C., Barnett, J. P., Adamu, A. H., Griffiths, E. J., Stewart, A. J. & Blindauer, C. A., 1 Nov 2019, In: Metallomics. 11, 11, p. 1805-1819 15 p.

    Research output: Contribution to journalArticlepeer-review

ID: 255043324

Top